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Abstract
Objective To explore the association between preterm delivery and
treatment at colposcopy.
Design Retrospective-prospective cohort study using record linkage.
Setting 12 National Health Service hospitals in England.
ParticipantsWomenwho had a cervical histology sample taken between
1987 and 2009. These women were linked by hospital episode statistics
to hospital obstetric records between 1998 and 2009 for the whole of
England to identify singleton live births between 20-43 gestational weeks
before or after cervical histology.
Main outcomemeasures Proportion of preterm births (<37 weeks); the
relative risk for the strength of association between preterm births and
treatment for cervical intraepithelial neoplasia.
Results 18 441 singleton births occurred: 4176 before histology and 14
265 after histology. Of the singleton births after histology, 9.0% (n=1284)
were preterm compared with 6.7% of all births in England over the same
period (excess risk 2.3 per 100 births, 95% confidence interval 1.8% to
2.8%). Among first births after histology, the adjusted relative risk
associated with previous treatment was 1.19 (95% confidence interval
1.01 to 1.41); among first births before histology the relative risk
associated with subsequent treatment was 1.47 (1.05 to 2.05). Combining
these, the relative risk associated with treatment adjusted for timing
relative to histology was 0.91 (0.66 to 1.26) corresponding to an absolute
difference of −0.25 (−2.61 to 2.11) per 100 singleton births. Among 372
women who gave birth both before and after treatment, there were 30
preterm births after treatment and 32 before treatment (relative risk 0.94,
0.62 to 1.43).
Conclusion The risk of preterm delivery in women treated by colposcopy
in England was substantially less than that in many other studies,
predominantly from Nordic countries. The increased risk may be a
consequence of confounding and not caused by treatment. Although
this study is reassuring for large loop excision of the transformation zone
overall, it is possible that deep conisation or repeated treatment leads
to an increased risk of preterm delivery.
Introduction
Screening for cervical cancer aims to detect and treat cancer
precursors (cervical intraepithelial neoplasia) before progression
to invasive cancer. Women with abnormal cytology are referred
to colposcopy for further assessment. In the United Kingdom,
most of these women will either have no procedure (and be
discharged) or have a punch biopsy sample taken at their first
colposcopy appointment to confirm the presence or absence of
disease, whereas others (particularly those with high grade
cytological abnormalities) may be offered excisional treatment
at the first visit.1 Those with a histological sample showing high
grade cervical intraepithelial neoplasia are commonly treated
by large loop excision of the transformation zone (LLETZ).
Other less common types of fertility preserving treatment include
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laser conisation, cold knife excision, cold coagulation, and other
ablative treatments.2
In recent years several studies have linked treatment for cervical
intraepithelial neoplasia with a higher risk of subsequent preterm
delivery (before 37 completed weeks of gestation). Preterm
infants are associated with substantial emotional and economic
costs to their families and communities and have a
disproportionate impact on health service utilisation. In 2006 a
widely cited meta-analysis of 27 included studies found that
large loop excision of the transformation zone was associated
with preterm delivery, low birth weight, and preterm premature
rupture of membranes.3 Since then several studies have been
published on this subject. The largest to date, a Norwegian
record linkage study of 57 136 births before treatment and 15
108 after treatment, found the proportion of preterm deliveries
in each group, respectively, to be 6.7% and 17.2%.4 Few studies
are from the United Kingdom and those that are tend to be
generally small5-9 and do not confirm the strong association
between treatment and subsequent preterm delivery found
elsewhere. Colposcopy and treatment of cervical intraepithelial
neoplasia in England is quality assured by the National Health
Service cervical screening programme and self regulated by the
British Society for Colposcopy and Cervical Pathology.10 It is
possible that the results reported internationally are not
representative of large loop excision of the transformation zone
as carried out by specially trained colposcopists working to
detailed clinical guidelines.
We explored the association between preterm delivery and
treatment at colposcopy by comparing three populations:
external (population of England), internal (within the cohort),
and within individual women. We reasoned that although
excisional treatment might result in a subsequent preterm
delivery, punch biopsy is too small to have such a causal role.
Furthermore, by definition treatment cannot affect the outcome
of a birth that occurred before that treatment. In our analyses
we adjusted for any increased risk associated with a history of
cervical intraepithelial neoplasia and focused on the association
with the treatment itself.
Methods
We identified women from clinical records in 12 NHS hospitals
as having had a cervical histology sample taken (by a punch
biopsy at colposcopy or excisional treatment, or both) between
January 1987 and December 2009. Hospitals included in the
study responded to an invitation for participation in a letter
posted on the British Society for Colposcopy and Cervical
Pathology website and sent to the hospitals’ mailing lists. A
prerequisite for participation was that the units had over 350
new referrals a year and support from their local research and
development office. Of units that expressed an interest we
selected the largest (>550 new referrals a year) in each region
of the country to ensure representation from all of England.
Three selected units could not obtain local ethical approval in
time and we substituted these with others in regions already
represented in the study and one with fewer than 300 referrals
a year.
For each woman, we obtained the date of the first and last
histological sample recorded in the clinic and requested the
most severe procedure (that is, whether it was a punch biopsy
or material from excisional treatment) carried out at these visits.
Thus we split our cohort into three groups: women with a punch
biopsy, women with excisional treatment, and women with a
record of cervical histology but missing treatment status. We
followed these women prospectively (through retrospective
linkage) for gestational age of subsequent births, and
retrospectively for gestational age of previous births.
To identify live births whether before or after the histological
sample had been obtained, we linked women by their NHS
number and date of birth to hospital episode statistics of inpatient
obstetric records between April 1998 and April 2010 for the
whole of England. The NHS number is a unique identifier issued
when a birth is registered or when an individual first registers
with an NHS general practitioner. Hospital episode statistics is
a data warehouse containing details of all admissions to NHS
hospitals in England, including private patients treated in NHS
hospitals.11 From hospital episode statistics records we obtained
information on month and year of delivery, gestational age,
birth weight, onset of delivery, mode of delivery, resuscitation
method, number of previous pregnancies, duration of stay in
hospital, and any inpatient diagnosis or operation recorded for
the mother.
National comparison
To obtain the proportion of preterm deliveries in the population
for the study period we extracted and pooled NHS maternity
statistics12 (published by hospital episode statistics) from
2000-01 to 2009-10. We were unable to find data before April
2000 and would have considered age standardised proportions,
but the published reports of gestational age by maternal age did
not separate singleton from multiple births as we have done
here.13
We considered only births with a known gestational age and
that were between 20 and 43 weeks. As best practice indicates
that pregnancies should not exceed the 42nd gestational week,
we excluded infants born at gestational ages greater than 43
weeks to avoid any inaccuracies of gestational ages over 43
weeks. Because of concerns over accuracy we also excluded
births with a recorded gestational age under 20 weeks (599
nationally and 16 in our cohort). We excluded multiple births
(twins and triplets). The same exclusions applied to the NHS
maternity statistics.
To avoid having to adjust for clustering of preterm deliveries
within individuals we limited the internal analysis to the first
pregnancy recorded in our cohort data during the 11 year period
between 1998 and 2010.We also excluded antepartum stillbirths
or stillbirths of indeterminate timing (n=216) on the basis that
we could not establish whether preterm delivery was induced
as a result of the death of the fetus or vice versa. Supplementary
table A1 shows the distribution of births in the cohort by parity,
whether the mother was treated before or after delivery, and
type of treatment received.
Statistical analysis
To obtain relative risks and 95% confidence intervals for the
difference in proportions of births that were preterm compared
with those that were term, we used relative risk regression (an
alternative to logistic regression for cohort studies) using the
glm command in Stata. We adjusted the relative risks for
maternal age at delivery (<25, 25-34, >34), parity (0, 1, 2, ≥3),
and study site. To determine parity in the cohort we used the
number of previous pregnancies recorded by hospital episode
statistics, except where a birth was found in the dataset that was
not reflected in the parity field. For completeness we also report
the results of risk differences, also estimated using the glm
command in Stata. P values cited are for the Pearson’s χ2 test
for the difference between proportions or for the likelihood ratio
test in other situations.
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We compared singleton births using three groups. The first
groups (external comparisons) were relative to NHS maternity
statistics for the whole of England. In the external comparisons
we compared all births in the cohort, all births after histology,
and births after treatment with all births in England. For the
internal comparisons we considered only first births in the
dataset and compared (a) births after histology with those before
histology, and births after treatment with each of (b) births
before treatment, (c) births after histology in untreated women,
and (d) births before histology in untreated women adjusting
for disease history. The within woman comparison was between
the last birth before colposcopy and the first after colposcopy
in a given woman. We considered all women with births both
before and after colposcopy and the subset of treated women.
We also considered the ratio of the after to before effect in
treated women relative to the effect in untreated women (that
is, with biopsy only). The confidence interval for the women
with biopsy only was obtained by treating the two relative risks
(within treated women and within untreated women) as
independent. In the within woman analyses we did not adjust
for parity or maternal age. For dealing with the question of the
effect of treatment on preterm delivery, we considered the most
relevant analyses to be for the external comparison, births after
treatment; for the internal comparison, births after treatment
compared with births before histology adjusting for disease
history; and for the within woman comparison, all treated
women with births before and after treatment.
The risk ratio comparing births after treatment with births before
histology adjusting for disease history is obtained from the
interaction term (1 for post-treatment, 0 otherwise) in a
generalised linear model with an effect for treatment (1 for
treated or subsequently treated, 0 otherwise) and an effect for
timing (1 for post-histology, 0 otherwise). In the absence of
other adjustments, it is simply the ratio of the relative risks of
preterm delivery in (a) births after treatment compared with
births after biopsy only to (b) births before treatment compared
with birth before biopsy only.
For comparison with published meta-analyses, we added our
study to those in the published meta-analysis of 27 included
studies to determine whether it differed significantly (taking
into account the heterogeneity in earlier studies) using the
metareg command in Stata. All analyses were done in Stata 11
(release 11.2. College Station, Texas).
Results
Participating hospitals
On average, the 12 participating clinics were similar to the other
215 clinics in England for published data on colposcopy (see
supplementary table A2). With one exception, the mean value
of each data item in participating clinics was within the
interquartile range of the other clinics. The one exception was
the proportion of biopsy results reported within eight weeks,
which was 83% in the study clinics but at least 86% in 75% of
other clinics nationally. The clinics included in this study
accounted for 8.5% of all patients having new colposcopy in
England in 2005-06.1
Cohort
A total of 44 210 NHS numbers of women with data on cervical
histology were submitted for linkage to hospital episode
statistics, 81.3% (35 958 women) had at least one hospital
admission between 1998 and 2009 and 46.8% (16 816/35 958)
of those with a record had at least one birth recorded. A total
of 26 897 births (in 16 816 women) were identified (fig 1⇓). Of
these, 18 441 were singleton births with known gestational age
between 20 and 43 gestational weeks, of which 1616 were
preterm (20-36 weeks) and 471 were very preterm (20-32
weeks). Table 1⇓ presents the proportion of births by maternal
age at delivery, parity, timing relative to colposcopy, and
procedure at colposcopy.
External comparison (population based)
The average preterm delivery rate in England between 2000
and 2010 was 6.7% (34 153/510 660, fig 2⇓). The preterm rate
varied from 6.9% in 2000 to 5.9% in 2009, with a minimum of
5.9% in 2009 and a maximum of 7.6% in 2004. Overall, the
observed preterm rate in our cohort was 8.8% (1616/18 441),
yielding an excess risk of preterm delivery of 2.08 per 100
singleton births (95% confidence interval 1.66% to 2.49%;
P<0.001) and a relative risk of 1.31 (95% confidence interval
1.25 to 1.37) compared with the general population. The
proportion of births after cervical histology that were preterm
was 9.0% (1284/14 265), giving an excess risk of 2.31 per 100
births (1.84% to 2.79%) and a relative risk of 1.35 (1.28 to 1.42)
compared with the general population. Similar results were
observed for deliveries after treatment (9.4%, 449/4776, table
2⇓). This relative risk (1.41, 1.29 to 1.54) was significantly
(P=0.03, even after allowing for heterogeneity in the
meta-analysis) lower than the comparable result in a
meta-analysis (1.97, 1.78 to 2.17).14 The proportion of preterm
births after histology, however, varied widely by hospital (fig
2) from 6.2% (161/2608, Wirral University Teaching Hospital)
to 15.6% (33/212, St Mary’s Hospital, Imperial College)
(χ211=66.07, P<0.001).
Internal comparison
For comparisons within the cohort only the first birth recorded
in the dataset was included for each woman, and antepartum
stillbirths and stillbirths of indeterminate timing were excluded.
This left 12 937 births of which 1099 (8.5%) were preterm.
Overall, 52.6% (n=578) of these preterm births had a gestational
age of 35-36 weeks, 19.3% (n=212) at 33-34 weeks, 17.5%
(n=192) at 29-32, and 10.6% (n=171) at 20-28 weeks. Themean
maternal age at first recorded delivery (n=12 937) was 31
(interquartile range 27-34) years.
Among singleton births delivered after cervical histology, 8.9%
(832/9368) were preterm compared with 7.5% (267/3569) of
those delivered before the date of histology (table 2). The
increase in risk of preterm delivery (adjusted by study site,
parity, and maternal age at delivery) was significant (adjusted
relative risk 1.32, 95% confidence interval 1.13 to 1.53). Figure
3⇓ plots the relative risks for all 12 study sites: there was no
evidence of heterogeneity between sites (χ211=11.574, P=0.40).
The type of sample taken at colposcopy was recorded for 80.6%
of births in the cohort (10 423 singleton births) including 77.8%
(n=855) of preterm deliveries. Of those that had a delivery after
colposcopy, the risk of preterm delivery in women who had a
treatment was 9.1% (283/3095) comparedwith 8.3% (396/4770)
in women who had a punch biopsy only (adjusted relative risk
1.19, 1.01 to 1.41). The absolute increased risk of preterm
delivery after treatment when compared with a biopsy only
adjusted for study site, parity, and maternal age was 1.5 per 100
births (0.1% to 2.9%).
The relative risks for treated versus punch biopsy were similar
for births before the histological sample was taken (table 3⇓).
Of births before histology, 7.8% (81/1045) of those in women
who were subsequently treated were preterm compared with
6.3% (95/1513) in womenwho subsequently had a punch biopsy
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and no treatment (adjusted relative risk 1.31, 0.97 to 1.76, table
3). Thus the risk ratio comparing births after treatment with
births before histology adjusting for disease history was 0.91
(95% confidence interval 0.66 to 1.26).
The proportion of births that were under 33 gestational weeks
(see supplementary table A3) in those women who had a
histology sample taken before birth was 2.8% (243/8779)
compared with 2.0% (66/3368) in women who had a histology
sample taken after birth (adjusted relative risk 1.60, 1.18 to
2.18). The adjusted relative risk in births after colposcopy
comparing treatment with biopsy only was 1.23 (0.89 to 1.69).
Further adjustment for disease history yielded a relative risk for
delivery under 33 weeks of 0.81 (0.43 to 1.52).
Since the analysis was limited to the first recorded birth in each
woman, the risk ratio (treated versus punch biopsy) was also
examined and was different in second or subsequent births after
colposcopy compared with first births after colposcopy. The
adjusted relative risk for treatment in second and subsequent
births after colposcopy was non-significantly (P=0.39) greater
than for first births after colposcopy, but similar to that of the
last birth before colposcopy (see supplementary table A4).
Within woman
An analysis was carried out restricted to women who had a birth
both before and after a colposcopy (within woman comparison,
table 2). For each woman the last birth before treatment and the
first birth after treatment was only included. This left 1078
women. There were 80 (7.4%) preterm births before colposcopy
and 98 (9.1%) after colposcopy (relative risk 1.23, 95%
confidence interval 0.95 to 1.59, P=0.15). In 372 women with
births both before and after treatment, there were 30 preterm
births after treatment and 32 before treatment (the relative risk
of preterm birth after treatment was 0.94, 0.62 to 1.43). In 501
women with births both before and after punch biopsy, the
relative risk of preterm birth after a punch biopsy was 1.14 (0.77
to 1.66). The ratio of the risk ratios (of preterm birth after:before
colposcopy) for treated compared with untreated (biopsy only)
women was 0.82 (0.27 to 3.17, see supplementary table A5).
Since in general the risk of a preterm birth is greater in a first
birth than in a second birth (8.8% v 7.6% in the study cohort,
table 1), and given that most womenwho gave birth both before
and after colposcopy had exactly one birth before colposcopy
(so that that second births were compared with first births), the
relative risk will have been underestimated. However, in women
with at least two births the risk of preterm on first birth was less
(8.1%), yielding a relative risk of 0.98 (0.85 to 1.13) for second
birth compared with first birth in women with at least two births.
Discussion
In this study of 18 441 singleton deliveries in women who had
a cervical biopsy sample taken during colposcopy in England,
the additional risk of a preterm birth over that in the general
population was 2.1 per 100 singleton births, yielding a relative
risk of 1.31. Comparing births in womenwithin the cohort (table
2), the relative risk in women who previously had treatment
(conisation, large loop excision of the transformation zone, loop
excision) compared with those who only had a biopsy was 1.19.
However, the relative risk of preterm delivery in women before
colposcopy comparing those who subsequently had treatment
with those who subsequently only had a biopsy was also greater
than 1 (1.33). Consequently the risk ratio comparing births after
treatment with births before histology adjusting for disease
history was less than 1, with an upper limit of the 95%
confidence interval of 1.26. Furthermore, in 372 women who
gave birth both before and after treatment for cervical
intraepithelial neoplasia, the number of births that were preterm
was fewer after treatment than before (30 v 32).
Strengths and limitations of the study
In considering causality in the absence of a randomised
controlled trial, we took into account confounding by risk
modifying factors and the temporality of cause and effect. We
allowed for the possibility of general confounding: factors (such
as smoking or ethnicity) that might predispose a woman to both
abnormal cervical cytology and preterm births; confounding by
disease severity—the possibility that factors (such as immune
suppression) that make it more likely for a woman to have high
grade disease (and be treated by cone excision) will also make
her more likely to have a preterm birth; and disease causing
prematurity—that the disease in itself (or factors that lead to its
presentation) rather than its treatment makes a woman more
likely to have a preterm birth. In our analyses we attempted to
take into account all three possible sources of confounding. The
first analyses included all singleton births in the cohort to ease
comparison with published population statistics. Although we
present the risk of preterm birth for both the whole cohort and
births after treatment, we did not adjust for possible
confounding. The internal analysis eliminates general
confounding because all women by definition have had
colposcopy. To exclude confounding by disease severity, we
considered women with treatment and compared births after
treatment with those before treatment. To exclude confounding
owing to disease causing preterm delivery, we compared births
after treatment with those after biopsy only. To take account of
both disease severity and temporality, we calculated the ratio
of these relative risks. This ratio was less than 1, suggesting
that the associations observed in the other analyses could all
result from confounding. Finally we took births before and after
colposcopy in the samewoman. Such an analysis is complicated
by changing parity and maternal age, but the relative risk after
treatment was less than 1. Additionally, the post-colposcopy
relative risk in treated women was less than that in women who
only had a punch biopsy (see supplementary table A5)
suggesting that confounding has not artificially reduced the
relative risk of treatment. However, for 19.4% of women we
do not know the type of procedure carried out at colposcopy.
This could have an important impact on the estimates comparing
treated with untreated women if, for instance, those with an
unknown procedure were more likely both to be treated and to
subsequently have a preterm birth. This problem will be further
investigated in phase 2 of this study (a nested case-control
study).
The results in this paper depend on the quality of birth data
submitted by participating clinics (NHS trusts) to hospital
episode statistics. The proportion of preterm births will also be
affected by the population served by the clinic. For example,
Whipps Cross Hospital serves a community with a high
proportion of ethnic minority groups, whereas St Mary’s
Hospital is a referral centre for high risk pregnancies from across
London.
There is also a question as to how representative the colposcopy
units in this study are of colposcopy done across England. The
12 participating units included both teaching and non-teaching
hospitals but were primarily self selected. We therefore
investigated the extent to which they seemed to be representative
of all colposcopy clinics in England on the basis of published
data. Comparing nationally collected statistics from the clinics
in this study with the other (n=215) clinics in England showed
that in terms of these statistics, the clinics in this study were not
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atypical of the rest of the country. Colposcopy clinics in England
are audited every three years, as are all colposcopists to maintain
their membership with the British Society for Colposcopy and
Cervical Pathology. Thus the standard of colposcopy in England
is likely to be more homogeneous than in many countries. Even
if treatment in smaller centres resulted in a greater risk of
preterm delivery, we believe that this study (with 8.5% of all
new patients in England) is representative of most colposcopy
in England.
We tried to minimise biases in this study by restricting the
analysis to the first live singleton birth recorded for each women
and by adjusting the relative risk by study centre. Additionally,
the design of the study avoided recall and selection bias.
However, we had no information on risk modifying factors such
as ethnicity or smoking, nor did we have any detailed
information on treatment received at colposcopy.
Comparison with other studies
This is the largest study of preterm delivery in women with
cytological abnormalities in the United Kingdom. A
meta-analysis including 30 cohort studies in total found that the
type of comparison group was important in determining the
relative risk of preterm delivery.14 When the comparison group
was external (such as the general population) the relative risk
of preterm delivery was 1.97 (95% confidence interval 1.78 to
2.17). Similarly, when the comparison group was internal
(comparing births after treatment with those before treatment),
the relative risk was 1.96 (1.46 to 2.64). However, when the
analysis was carried out within a cohort of women with
cytological abnormalities comparing treated with untreated
women, the relative risk was 1.25 (0.98 to 1.58). Three studies
from Nordic countries obtained relative risks between 1.8 and
2.8 (all except one not included in the meta-analysis). Of the
excluded studies, a large study from Norway found a relative
risk of 2.13 (95% confidence interval 2.06 to 2.20) comparing
(all not just singleton) births after treatment with births before
treatment, but reported a declining relative risk during the study
period.4 The absolute risk was 17.2% (in 15 108 births after
treatment). Our preterm risk in treated women is clearly less.
A study from Denmark had a relative risk of 2.8 (95%
confidence interval 2.3 to 3.5) compared with an external control
group.15 The same study also provided a within woman odds
ratio of 2.8 (95% confidence interval 1.0 to10.0) as did a study
from Finland (1.8, 95% confidence interval 1.04 to 3.21).16
The relative risk of preterm delivery after treatment observed
in this study compared with the population as a whole is
substantially (and significantly) less than that found in the
studies included in the Bruinsma meta-analysis.14 Additionally,
our internal analyses tend not to support the hypothesis that
treatment increases the risk of preterm delivery, by a factor of
about 1.7 to 2.0; the analysis that adjusts for both the timing of
the delivery relative to colposcopy and whether there was
treatment or just a punch biopsy gives a relative risk of 0.91
(95% confidence interval 0.66 to 1.26) for births subsequent to
treatment.
Several studies have suggested that it is the amount of tissue
removed from the cervix that produces the excess risk, not the
procedure itself.17-19 It is possible that owing to the quality
assurance of the colposcopy programme in England through
both the cervical screening programme and the British Society
for Colposcopy and Cervical Pathology, tissue removed during
colposcopy is kept to a minimum and this could explain the
smaller relative risks that we observed. This might be
particularly relevant in the self selected colposcopy units in this
study. We are currently undergoing phase 2 of this study in
which we will attempt to obtain detailed colposcopy and
pathology information on all women with a preterm delivery
and a sample of women with a term delivery in this cohort. In
particular, we are recording the measurements of the tissue
excised and whether the woman was treated more than once. It
seems likely that removal or destruction of a large amount of
tissuemay increase the risk of subsequent preterm deliverymore
than is seen on average.
Conclusions and policy implications
The results presented here are encouraging. Accepting the
limitations of this study, women treated within the NHS cervical
screening programme and particularly those treated in large
colposcopy units should be reassured that, in this study of 44
000women having colposcopy including 14 265 singleton births
after colposcopy, the risk of a birth being preterm was 9.0%
and only slightly greater than the risk in the general population.
Phase 2 of this study should strengthen the results presented
here and provide information on the risk associated with the
depth of cervical tissue removed.
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Tables
Table 1| Proportion of births by maternal age at delivery, parity, timing relative to colposcopy, and procedure at colposcopy
% (No) very preterm*% (No) pretermTotal NoCharacteristics
Maternal age at delivery:
2.5 (10)8.1 (32)395<20
2.8 (56)9.7 (196)201320-24
2.7 (136)8.7 (440)508225-29
2.5 (162)8.8 (579)659030-34
2.5 (92)8.6 (320)370335-39
2.3 (15)7.5 (49)658≥40
Parity†:
2.6 (237)8.8 (799)90940
2.0 (100)7.6 (376)49601
2.5 (55)9.1 (201)22202
3.0 (33)8.7 (95)10913
4.3 (46)13.5 (145)1076≥4
Timing:
2.1 (88)8.0 (332)4176Pre-colposcopy
2.7 (383)9.0 (1284)14 265Post-colposcopy
Procedure:
2.2 (195)7.8 (705)8999Punch biopsy
3.0 (178)9.2 (547)5949LLETZ/loop/cone
2.8 (98)10.4 (364)3493Unknown
Timing×procedure
Birth pre-colposcopy:
1.8 (31)6.9 (119)1736Punch biopsy
3.0 (35)8.4 (98)1173Treatment
1.7 (22)9.1 (115)1267Unknown
Birth post-colposcopy:
2.3 (164)8.1 (586)7263Punch biopsy
3.0 (143)9.4 (449)4776Treatment
3.4 (76)11.2 (249)2226Unknown
100 (471)100 (1616)18 441Total
LLETZ=large loop excision of the transformation zone.
*Births under 33 gestational weeks.
†As recorded in hospital episode statistics, except when number of births in the dataset was greater than that recorded by hospital episode statistics.
No commercial reuse: See rights and reprints http://www.bmj.com/permissions Subscribe: http://www.bmj.com/subscribe
BMJ 2012;345:e5174 doi: 10.1136/bmj.e5174 (Published 16 August 2012) Page 7 of 11
RESEARCH
Table 2| Summary of analyses and results
Relative risk (95% CI)Excess risk per 100 (95% CI)Crude rate (%) (preterm)Total No of birthsAnalyses
——6.7510 660England
External (versus England)
1.31 (1.25 to 1.37)2.08 (1.66 to 2.49)8.818 441All cohort
1.35 (1.28 to 1.42)2.31 (1.84 to 2.79)9.014 265All post-histology
1.41 (1.29 to 1.54)2.71 (1.88 to 3.54)9.44776Post-treatment
Internal*
——8.99368All post-histology:
1.32 (1.13 to 1.53)2.13 (0.99 to 3.27)7.53569Versus all pre-histology
——9.13095Post-treatment:
1.33 (1.04 to 1.70)2.31 (0.34 to 4.33)7.81045Versus pre-treatment
1.19 (1.01 to 1.41)1.49 (0.05 to 2.95)8.34770Versus post-biopsy
0.91 (0.66 to 1.26)−0.25 (−2.61 to 2.11)——Adjusted
Within woman/matched pairs
——9.11078All post-histology:
1.23 (0.95 to 1.59)1.67 (−0.54 to 3.88)7.41078Versus all pre-histology
——8.1372All treated post-histology
0.94 (0.62 to 1.43)−0.54 (−4.30 to 3.23)8.6372Versus pre-histology
*Excess risk and relative risk adjusted by study site, parity, and maternal age at delivery.
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Table 3| Adjusted relative risks for association between cervical histology and preterm delivery
Adjusted relative risk* (95% CI)
post:pre-colposcopy
Birth before colposcopyBirth after colposcopy
Variables % (No) pretermTotal% (No) pretermTotal
1.33 (1.04 to 1.70)81 (7.8)10459.1 (283)3095LLETZ/loop/cone
1.45 (1.15 to 1.83)95 (6.3)15138.3 (396)4770Punch biopsy
0.91 (0.66 to 1.26)1.31 (0.97 to 1.76)1.19 (1.01 to 1.41)Adjusted relative risk* (95%CI) cone:punch
LLETZ=large loop excision of the transformation zone.
*Adjusted by study site, parity, and maternal age at delivery.
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Figures
Fig 1 Flow of women through study
Fig 2 Proportion of preterm deliveries after colposcopy by study centre, overall, and compared with England
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Fig 3 Relative risk of preterm birth in women with a birth after compared with before colposcopy
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